Kristen Stants
Nessuna posizione attualmente
Profilo
Kristen Stants worked as a Senior Director-Human Resources Business Partner at Biogen, Inc. from 2013 to 2016.
She then worked as Vice President-Talent Strategy at Alexion Pharmaceuticals, Inc. from 2017 to 2019.
In 2016 to 2017, she was Vice President-Global Talent Management at Patheon Pharmaceuticals, Inc. Currently, she is the Chief People Officer at Magenta Therapeutics, Inc. starting from 2020 to 2023.
Ms. Stants graduated from Cornell University with a graduate degree and from the University of Oregon with an undergraduate degree.
Precedenti posizioni note di Kristen Stants
| Società | Posizione | Fine |
|---|---|---|
| MAGENTA THERAPEUTICS | Ufficiale delle Risorse Umane | 07/02/2023 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2019 |
Patheon Pharmaceuticals, Inc.
 Patheon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Patheon, Inc., Patheon Pharmaceuticals, Inc. is a trusted end-to-end contract development and manufacturing organization partner for the pharmaceutical, biotech, and life sciences industries. The company is based in Durham, NC. Benefit from a single vendor along your entire development journey by relying on their clinical trial services’ support network and expertise. | Corporate Officer/Principal | 01/10/2017 |
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2016 |
Formazione di Kristen Stants
| Cornell University | Graduate Degree |
| University of Oregon | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Patheon Pharmaceuticals, Inc.
Patheon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Patheon, Inc., Patheon Pharmaceuticals, Inc. is a trusted end-to-end contract development and manufacturing organization partner for the pharmaceutical, biotech, and life sciences industries. The company is based in Durham, NC. Benefit from a single vendor along your entire development journey by relying on their clinical trial services’ support network and expertise. | Health Technology |
- Borsa valori
- Insiders
- Kristen Stants
